An increase in serum phosphate by sodium arginate.
スポンサーリンク
概要
- 論文の詳細を見る
Sodium arginate has been reported to have hematostatic effects, and prescribed safely for patients with renal failure. There are no side effect other than mild constipation or diarrhea known to date, but we have observed an interaction with calcium bicarbonate, major phosphate binder in Japan, in 2 patients receiving hemodialysis. The reason for clinical observation, the increase in serum phosphate concentration with the administration of sodium arginate, was supposed by experiment. Contrary to our expectation that sodium arginate and calcium would form a compound, sodium arginate swallowed up the calcium bicarbonate in acidified saline. It is recommended that the hours of administration be staggered when both agents are prescribed.
- 社団法人 日本透析医学会の論文
社団法人 日本透析医学会 | 論文
- 4．血液浄化療法の生体適合性と腎性貧血
- PD-HD併用療法においての腎機能保護の可能性 : 第51回日本透析医学会ワークショップより
- 腹部大動脈人工血管の仮性動脈瘤破裂，および右大腿回旋動脈の仮性動脈瘤破裂をきたした血液透析患者の1例
- 5．透析患者のインスリン抵抗性と腎性貧血
- 摘出腫瘤の病理組織標本所見より頸椎腫瘍状石灰沈着症 (cervical tumoral calcinosis) と診断し得た維持透析患者の1例